AstraZeneca (United States)

7.0k papers and 231.3k indexed citations

About

In recent decades, authors affiliated with AstraZeneca (United States) have published 7.0k papers, which have received a total of 231.3k indexed citations. Scholars at this organization have produced 1.7k papers in Molecular Biology, 1.7k papers in Pulmonary and Respiratory Medicine and 1.6k papers in Oncology on the topics of Asthma and respiratory diseases (597 papers), Lung Cancer Treatments and Mutations (489 papers) and Diabetes Treatment and Management (436 papers). Their work is cited by papers focused on Molecular Biology (61.0k citations), Oncology (44.8k citations) and Pulmonary and Respiratory Medicine (42.2k citations). Authors at AstraZeneca (United States) collaborate with scholars in United States, United Kingdom and Sweden and have published in prestigious journals including Nature, Science and New England Journal of Medicine. Some of AstraZeneca (United States)'s most productive authors include John J.V. McMurray, Eric L. Michelson, Dean G. Brown, Salim Yusuf, Karl Swedberg, Marc A. Pfeffer, Christopher B. Granger, Jonas Boström, Shamik Parikh and Paul D. Lyne.

In The Last Decade

AstraZeneca (United States)

6.6k papers receiving 229.0k citations

Countries citing scholars working at AstraZeneca (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at AstraZeneca (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AstraZeneca (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AstraZeneca (United States) more than expected).

Fields of papers published by authors at AstraZeneca (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with AstraZeneca (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with AstraZeneca (United States) at the time of their publication.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Janssen (United States) Breakdown of academic impact, for scholars at Novartis (United States) Breakdown of academic impact, for scholars at Weill Cornell Medicine Breakdown of academic impact, for scholars at GlaxoSmithKline (United States) Breakdown of academic impact, for scholars at Center for Drug Evaluation and Research Breakdown of academic impact, for scholars at Boehringer Ingelheim (United States) Breakdown of academic impact, for scholars at Feinstein Institute for Medical Research Breakdown of academic impact, for scholars at Bristol-Myers Squibb (United States) Breakdown of academic impact, for scholars at Sidney Kimmel Cancer Center Breakdown of academic impact, for scholars at Sanofi (United States)
Rankless by CCL
2026